Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IIB-IIIA RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 177 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kittusamy, PK; Koenigsberg, RA; McCormick, DJ
      Abciximab for the treatment of acute distal embolization associated with internal carotid artery angioplasty

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    2. Braunwald, E
      Early intervention and abciximab - preserving myocardium - Proceedings of an International Symposium held in Paris, France, 23-26 May 2000 - Foreword

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    3. Montalescot, G; Choussat, R; Collet, JP
      Glycoprotein IIb/IIIa receptors and primary stenting in acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    4. Antman, EM; de Lemos, JA; Braunwald, E
      Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    5. Neumann, FJ
      Optimization of microvascular reperfusion in acute myocardial infarction

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    6. Kovacs, MS; Hein, P; Sattarzadeh, S; Patrick, BO; Emge, TJ; Orvig, C
      Complexes of phosphine-phenolate ligands with the [Re=O](3+) and [Re(HNNC5H4N)(NNC5H4N)](2+) cores

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    7. McKenzie, ME; Gurbel, PA
      The potential of monoclonal antibodies to reduce reperfusion injury in myocardial infarction

      BIODRUGS
    8. Clutton, P; Folts, JD; Freedman, JE
      Pharmacological control of platelet function

      PHARMACOLOGICAL RESEARCH
    9. Liu, S; Edwards, DS
      Stabilization of Y-90-labeled DOTA-biomolecule conjugates using gentisic acid and ascorbic acid

      BIOCONJUGATE CHEMISTRY
    10. Easton, JD
      Future perspectives for optimizing oral antiplatelet therapy

      CEREBROVASCULAR DISEASES
    11. Haase, KK; Koenig, W
      Clinical benefit of glycoprotein IIb/IIIa receptor antagonists in patientswith acute coronary syndrome

      PERFUSION
    12. Mukherjee, D; Chew, DP; Robbins, M; Yadav, JS; Raymond, RE; Moliterno, DJ
      Clinical application of procedural platelet monitoring during percutaneouscoronary intervention among patients at increased bleeding risk

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    13. Smith, BS; Gandhi, PJ
      Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins andglycoprotein IIb/IIIa receptor antagonists in renal failure

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    14. Lin, PH; Bush, RL; Tong, FC; Chaikof, E; Martin, LG; Lumsden, AB
      Intra-arterial thrombin injection of an ascending aortic pseudoaneurysm complicated by transient ischemic attack and rescued with systemic abciximab

      JOURNAL OF VASCULAR SURGERY
    15. Schuhlen, H; Kastrati, A; Pache, J; Dirschinger, J; Schomig, A
      Incidence of thrombotic occlusion and major adverse cardiac events betweentwo and four weeks after coronary stent placement: Analysis of 5,678 patients with a four-week ticlopidine regimen

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    16. Roe, MT; Ohman, EM; Maas, ACP; Christenson, RH; Mahaffey, KW; Granger, CB; Harrington, RA; Califf, RM; Krucoff, MW
      Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    17. Sassoli, PM; Emmell, EL; Tam, SH; Trikha, M; Zhou, Z; Jordan, RE; Nakada, MT
      7E3 F(ab ')(2), an effective antagonist of rat alpha IIb beta 3 and alpha v beta 3, blocks in vivo thrombus formation and in vitro angiogenesis

      THROMBOSIS AND HAEMOSTASIS
    18. Christov, A; Kostuk, WJ; Jablonsky, G; Lucas, A
      Fluorescence spectroscopic analysis of circulating platelet activation during coronary angioplasty

      LASERS IN SURGERY AND MEDICINE
    19. Zwart-van Rijkom, JEF; Klungel, OH; Leufkens, HGM; Broekmans, AW; Schrijver-van Velthoven, S; Umans, VA
      Costs and effects of combining stenting and abciximab (ReoPro (R)) in daily practice

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    20. Suvire, FD; Rodriguez, AM; Mak, ML; Papp, JG; Enriz, RD
      Binding mechanism of RGD and its mimetics to receptor GPIIb/IIIa. A theoretical study

      JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    21. Truong, KM; Amankwa, K; Kucukarslan, S
      Platelet glycoprotein IIb/IIIa-receptor inhibitors in patients with acute coronary syndromes or undergoing percutaneous coronary interventions: A review

      CLINICAL THERAPEUTICS
    22. Dixon, SR; O'Neill, WW
      Interventions in acute myocardial infarction

      CURRENT PROBLEMS IN CARDIOLOGY
    23. Verheugt, FWA
      GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction

      THROMBOSIS RESEARCH
    24. Kageyama, S; Yamamoto, H; Nakazawa, H; Yoshimoto, R
      Anti-human vWF monoclonal antibody, AJvW-2 fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs

      THROMBOSIS RESEARCH
    25. Fintel, DJ
      From bench to bedside - GP IIb-IIIa inhibitors

      NEUROLOGY
    26. Yang, Y; Li, Q; Nakada, MT; Yang, T; Shuaib, A
      Angiographic evaluation of middle cerebral artery reperfusion caused by platelet glycoprotein IIb/IIIa receptor complex antagonist murine 7E3 F(ab ')(2) in a model of focal cerebral ischemia in rats

      JOURNAL OF NEUROSURGERY
    27. Babich, JW; Graham, W; Femia, FJ; Dong, Q; Barzana, M; Ferrill, K; Fischman, AJ; Zubieta, J
      6-mercaptomethylpyridine-3-carboxylic acid (MEMNIC): a new reagent for peptide labeling with Tc-99m

      INORGANICA CHIMICA ACTA
    28. Schibli, R; Katti, KV; Volkert, WA; Barnes, CL
      Development of novel water-soluble, organometallic compounds for potentialuse in nuclear medicine: Synthesis, characterization, and H-1 and P-31 NMRinvestigations of the complexes fac-[ReBr(CO)(3)L] (L = bis(bis(hydroxymethyl)phosphino)ethane, bis(bis(hydroxymethyl)phosphino)benzene)

      INORGANIC CHEMISTRY
    29. Lincoff, AM; Kereiakes, DJ; Mascelli, MA; Deckelbaum, LI; Barnathan, ES; Patel, KK; Frederick, B; Nakada, MT; Topol, EJ
      Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

      CIRCULATION
    30. Chang, MY; Chen, ST
      Concise synthesis of sibrafiban and lamifiban, two non-peptide fibrinogen receptor (GP IIb/IIIa) antagonists

      JOURNAL OF THE CHINESE CHEMICAL SOCIETY
    31. Patel, RK; Savidge, GF; Rangarajan, S
      Use of recombinant factor VIIA for post-operative haemorrhage in a patientwith Glanzmann's thrombasthenia and human leucocyte antigen antibodies

      BRITISH JOURNAL OF HAEMATOLOGY
    32. Rosado, JA; Meijer, EMY; Hamulyak, K; Novakova, I; Heemskerk, JWM; Sage, SO
      Fibrinogen binding to the integrin alpha(IIb)beta(3) modulates store-mediated calcium entry in human platelets

      BLOOD
    33. Mease, RC; Lambert, C
      Newer methods of labeling diagnostic agents with Tc-99m

      SEMINARS IN NUCLEAR MEDICINE
    34. Schneiderman, J; Morag, B; Gerniak, A; Rimon, U; Varon, D; Seligsohn, U; Shotan, A; Adar, R
      Abciximab in carotid stenting for postsurgical carotid restenosis: Intermediate results

      JOURNAL OF ENDOVASCULAR THERAPY
    35. Brogan, GX
      Managing chest pain in the emergency room

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    36. Kang, YK; Jhon, JS
      Preferred conformations of a linear RGD tripeptide

      JOURNAL OF PEPTIDE RESEARCH
    37. Dal Pozzo, A; Fagnoni, N; Bergonzi, R; Vanini, L; de Castiglione, R; Aglio, C; Colli, S
      Synthesis and anti-aggregatory activity of linear retro-inverso RGD peptides

      JOURNAL OF PEPTIDE RESEARCH
    38. Liu, FQ; Craft, RM; Morris, SA; Carroll, RC
      Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    39. Kupatt, C; Wichels, R; Becker, BF; Boekstegers, P
      Inhibition of post-ischaemic inflammation as a therapeutic approach to myocardial ischaemia reperfusion injury

      EXPERT OPINION ON THERAPEUTIC PATENTS
    40. Kupatt, C; Habazettl, H; Hanusch, P; Wichels, R; Hahnel, D; Becker, BF; Boekstegers, P
      c7E3Fab reduces postischemic leukocyte-thrombocyte interaction mediated byfibrinogen - Implications for myocardial reperfusion injury

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    41. Frangos, SG; Chen, AH; Sumpio, B
      Vascular drugs in the new millennium

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    42. White, HD
      Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: Complementary or competing therapies?

      JOURNAL OF INVASIVE CARDIOLOGY
    43. Koestenberger, M; Gallistl, S; Cvirn, G; Roschitz, B; Muntean, W
      Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro

      BLOOD COAGULATION & FIBRINOLYSIS
    44. Steinhubl, SR
      Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    45. Li, YF; Spencer, FA; Ball, S; Becker, RC
      Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: Potential contributing mechanism of benefit in acute coronary syndromes

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    46. Talley, JD
      Pharmacology of GP IIb-IIIa platelet inhibitors, part IV

      JOURNAL OF INTERVENTIONAL CARDIOLOGY
    47. Hezard, N; Metz, D; Garnotel, R; Droulle, C; Potron, G; Nguyen, P
      Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation.

      JOURNAL DES MALADIES VASCULAIRES
    48. Kumar, A; Schaub, RG
      Adjunctive therapies for enhancing the effect of currently available thrombolytic agents

      DRUGS OF THE FUTURE
    49. Hezard, N; Metz, D; Nazeyrollas, P; Droulle, C; Elaerts, J; Potron, G; Nguyen, P
      Use ct the PFA-100 (TM) apparatus to assess platelet function in patients undergoing PTCA during and after infusion of cE3 Fab in the presence of other antiplatelet agents

      THROMBOSIS AND HAEMOSTASIS
    50. Peter, K; Nordt, T; Bode, C
      Therapeutic inhibition of platelets in acute coronary syndrome and in coronary intervention: mechanisms and clinical results

      ZEITSCHRIFT FUR KARDIOLOGIE
    51. Akkerhuis, KM; Deckers, JW; Boersma, E; Harrington, RA; Stepinska, J; Mahaffey, KW; Wilcox, RG; Lincoff, AM; Keltai, M; Topol, EJ; Califf, RM; Simoons, ML
      Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT

      EUROPEAN HEART JOURNAL
    52. Tong, FC; Cloft, HJ; Joseph, GJ; Samuels, OB; Dion, JE
      Abciximab rescue in acute carotid stent thrombosis

      AMERICAN JOURNAL OF NEURORADIOLOGY
    53. Cannon, CP
      Learning from the recently completed oral glycoprotein IIb/IIIa receptor antagonist trials

      CLINICAL CARDIOLOGY
    54. Topol, EJ
      The future of antiplatelet therapy: Optimizing management in patients withacute coronary syndrome

      CLINICAL CARDIOLOGY
    55. Yomo, T; Serna, DL; Powell, LL; Wang, D; Wilson, SE; Ishimaru, S; Chen, JC
      Glycoprotein IIb/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in vitro nonpulsatile ventricular assist circulation

      ARTIFICIAL ORGANS
    56. Mousa, SA
      Comparative efficacy of different low-molecular-weight heparins (LMWHs) and drug interactions with LMWH: Implications for management of vascular disorders

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    57. Ogawa, T; Sugidachi, A; Naganuma, H; Asai, F
      Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs

      THROMBOSIS RESEARCH
    58. Straumann, E; Naegeli, B; Frielingsdorf, J; Gerber, A; Mury, R; Schuiki, E; Bertel, O
      Interventional management of acute myocardial infarction

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    59. Cusack, M; Redwood, S; Coltart, J
      Recent advances in ischaemic heart disease

      POSTGRADUATE MEDICAL JOURNAL
    60. Brodison, A; Katira, R; More, RS; Chauhan, A
      Antiplatelet use in interventional cardiology

      POSTGRADUATE MEDICAL JOURNAL
    61. Lqbal, O; Walenga, JM; Lewis, BE; Bakhos, M
      Bleeding complications with glycoprotein llb/llla inhibitors

      DRUGS OF TODAY
    62. Femia, FJ; Chen, XY; Maresca, KP; Babich, JW; Zubieta, J
      Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands

      INORGANICA CHIMICA ACTA
    63. Babich, JW; Coco, WG; Barrow, S; Fischman, AJ; Femia, FJ; Zubieta, J
      Tc-99m-labeled chemotactic peptides: influence of coligand on distributionof molecular species and infection imaging properties. Synthesis and structural characterization of model complexes with the {Re(eta(2)-HNNC5H4N)(eta(1)-NNC5H4N)} core

      INORGANICA CHIMICA ACTA
    64. Femia, FJ; Chen, XY; Maresca, KP; Babich, JW; Zubieta, J
      Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC4H3N2)(NNC4H3N2)(OCH3)(2)](4)

      INORGANICA CHIMICA ACTA
    65. Katoh, M; Karasawa, T; Doi, H; Odawara, A; Takagi, M; Ikeo, T; Narita, H
      Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    66. Royo, T; Alfon, J; Berrozpe, M; Badimon, L
      Effect of gemfibrozil on peripheral atherosclerosis and platelet activation in a pig model of hyperlipidemia

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    67. Kaushansky, K
      Blood: New designs for a new millennium

      BLOOD
    68. Bonnefoy, A; Liu, QD; Legrand, C; Frojmovic, MM
      Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow

      BIOPHYSICAL JOURNAL
    69. Giri, S; Mitchel, JF; Hirst, JA; McKay, RG; Azar, RR; Mennett, R; Waters, DD; Kiernan, FJ
      Synergy between intracoronary stenting and abciximab improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction

      AMERICAN JOURNAL OF CARDIOLOGY
    70. Roberts, WC; Fuster, V
      Valentin Fuster, MD, PhD: A conversation with the editor

      AMERICAN JOURNAL OF CARDIOLOGY
    71. Yamada, DM; Topol, EJ
      Importance of microembolization and inflammation in atherosclerotic heart disease

      AMERICAN HEART JOURNAL
    72. Li, RH; Herrmann, HC
      Facilitated percutaneous coronary intervention: A novel concept in expediting and improving acute myocardial infarction care

      AMERICAN HEART JOURNAL
    73. Harrington, RA
      The PURSUIT results in perspective

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    74. Jordan, R; Mascelli, MA
      Pharmacological differentiation of GP IIb/IIIa inhibitors

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    75. Chronos, N; Marciniak, SJ; Nakada, MT
      Binding specificity and associated effects of platelet GP IIb/IIIa inhibitors

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    76. Lincoff, AM; Korngold, S
      An overview of platelet GP IIb/IIIa receptor antagonists trials

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    77. Kleiman, NS; Tcheng, JE
      Safety issues surrounding use of platelet GP IIb/IIIa antagonists: reversibility and readministration

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    78. Hermiller, J; Kereiakes, DJ
      Economic considerations in the use of the platelet GP IIb/IIIa inhibitor abciximab in percutaneous coronary intervention

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    79. Robinson, N; Barakat, K; Dymond, D
      Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus

      HEART
    80. Bessmertny, O; Cheng, JWM
      Overview of platelet glycoprotein IIb IIIa receptor antagonist treatment in the management of coronary interventions and acute ischemic coronary syndromes

      AMERICAN JOURNAL OF MANAGED CARE
    81. Mousa, SA; Kapil, R; Mu, DX
      Intravenous and oral antithrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban (DMP754) and its free acid form, XV459

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    82. Stringer, KA
      The evolving role of platelet glycoprotein IIb IIIa inhibitors in the management of acute coronary syndromes

      ANNALS OF PHARMACOTHERAPY
    83. Edwards, DS; Liu, S; Harris, AR; Poirier, MJ; Ewels, BA
      Tc-99m-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclicpeptide

      BIOCONJUGATE CHEMISTRY
    84. Edwards, DS; Liu, S; Ziegler, MC; Harris, AR; Crocker, AC; Heminway, SJ; Barrett, JA; Bridger, GJ; Abrams, MJ; Higgins, JD
      RP463: A stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging

      BIOCONJUGATE CHEMISTRY
    85. Ono, M; Arano, Y; Uehara, T; Fujioka, Y; Ogawa, K; Namba, S; Mukai, T; Nakayama, M; Saji, H
      Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins

      BIOCONJUGATE CHEMISTRY
    86. Karra, SR; Schibli, R; Gali, H; Katti, KV; Hoffman, TJ; Higginbotham, C; Sieckman, GL; Volkert, WA
      Tc-99m-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent

      BIOCONJUGATE CHEMISTRY
    87. Edwards, DS; Liu, S
      Tc-99m radiopharmaceuticals based on a ternary ligand system comprised of a water soluble phosphine

      PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS
    88. Amidon, TM; Amidon, JB; Benson, JM; Coffler, D
      Tirofiban and intracoronary stenting: Evaluation of a new pharmacologic regimen

      JOURNAL OF INVASIVE CARDIOLOGY
    89. Lucore, CL; Mishkel, GJ; Ligon, RW; Rocha-Singh, K
      Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital

      JOURNAL OF INVASIVE CARDIOLOGY
    90. Decristoforo, C; Mather, SJ
      99m-technetium-labelled peptide-HYNIC conjugates: Effects of lipophilicityand stability on biodistribution

      NUCLEAR MEDICINE AND BIOLOGY
    91. Roe, MT; Moliterno, DJ
      Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB IIIA inhibitors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    92. Kereiakes, DJ; Mueller, M; Howard, W; Lacock, P; Anderson, LC; Broderick, TM; Roth, EM; Whang, DD; Abbottsmith, CW
      Efficacy of abciximab induced platelet blockade using a rapid point of care assay

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    93. O'Neill, WW; Serruys, P; Knudtson, M; Van Es, GA; Timmis, GC; van der Zwaan, C; Kleiman, J; Barker, K; Dreiling, R; Hubbard, R; Alexander, J; Anders, R
      Design and objectives of the Evaluation of Oral Xemilofiban in ControllingThrombotic Events (EXCITE) study

      JOURNAL OF INTERVENTIONAL CARDIOLOGY
    94. Saji, H
      Targeted delivery of radiolabeled imaging and therapeutic agents: Bifunctional radiopharmaceuticals

      CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
    95. Hezard, N; Metz, D; Nazeyrollas, P; Nguyen, P; Simon, G; Daliphard, S; Droulle, C; Elaerts, J; Potron, G
      Free and total platelet glycoprotein IIb IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA

      THROMBOSIS AND HAEMOSTASIS
    96. Abrahamian, H
      Inhibition of platelet aggregation in diabetic patients

      ACTA MEDICA AUSTRIACA
    97. Taillefer, R; Therasse, E; Turpin, S; Lambert, R; Robillard, P; Soulez, G
      Comparison of early and delayed scintigraphy with Tc-99m-apcitide and correlation with contrast-enhanced venography in detection of acute deep vein thrombosis

      JOURNAL OF NUCLEAR MEDICINE
    98. Cohen, M; Ferguson, JJ; Harrington, RA
      Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: Applicability to the practice of medicine in the United States

      CLINICAL CARDIOLOGY
    99. Baker, RI; Hankey, GJ
      Antiplatelet drugs

      MEDICAL JOURNAL OF AUSTRALIA
    100. Dyke, C; Bhatia, D
      Inhibitors of the platelet receptor glycoprotein IIb-IIIa and complications during percutaneous coronary revascularization - Management strategies for the cardiac surgeon

      JOURNAL OF CARDIOVASCULAR SURGERY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 15:59:36